1. CRISPR-Cas9-based target validation for p53-reactivating model compounds. (July 2016) Authors: Wanzel, M.; Vischedyk, J.; Gittler, M.; Gremke, N.; Mernberger, M.; Charles, J.; Schneikert, J.; Bretz, A.C.; Nist, A.; Stiewe, T. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Monitoring the dynamics of clonal tumor evolution in vivo using secreted luciferases. (July 2016) Authors: Charles, J.P.; Fuchs, J.; Hefter, M.; Vischedyk, J.B.; Kleint, M.; Vogiatzi, F.; Nist, A.; Timofeev, O.; Wanzel, M.; Stiewe, T. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Mutant p53 promotes tumor progression by the endoplasmic reticulum UDPase ENTPD5. (July 2016) Authors: Vogiatzi, F.; Brandt, D.T.; Fuchs, J.; Grikscheit, K.; Timofeev, O.; Nist, A.; Mernberger, M.; Grosse, R.; Stiewe, T. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Widespread epigenetic activation of ΔNp73 in small cell lung cancer causes vulnerability to Tip60-p400 inhibition. (July 2016) Authors: Nist, A.; Krampitz, A.M.; Schlereth, K.; Mernberger, M.; Moßner, M.C.; Muley, T.; Dammann, R.; Stiewe, T. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗